SONOKLINIKKEN AS
Operating
Selskapets formål er å drive konservativ fysikalsk/medisinsk
behandling av smerter i muskel- og skjelettapparatet i tråd med
Klinisk Ortopedisk Medisin ad modum Cyriax og andre tjenester som
naturlig faller sammen med dette. Lokalene kan også leies ut til
dertil egnet virksomhet.
Cyriax Clinic AS driv konservativ fysikalsk/medisinsk behandling av
smerter frå muskel-og skjelettapparatet med utgangspunkt i Klinisk
Ortopedisk Medisin ad modum Cyriax. Behandlingsformer inkluderer
injeksjonsbehandling, manipulasjon/traksjon/mobilisering, dry
needling, treningsveiledning.
Organization
- Chairman of the board
- SR
Sindre Romarheim1979
- Years since formation
- 14 years
- since Jan 27, 2012
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 300
- 1 share class
- Total number of shareholders
- 4
- 1 company, 3 persons
Financials
- Total operating income 2025
- 2,224,698
- NOK
- Annual total result 2025
- 362,281
- NOK
- Total equity 2025
- 471,378
- NOK
Last update: Jun 23, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
SR 1979 | Chairman | 45 % directly |
EG 1982 | Board Member | 45 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
EG 1982 | Board Member | 45 % directly |
SR 1979 | Chairman | 45 % directly |
NM 1991 | - | 5 % indirectly |
BK | - | 5 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
EG 1982 | Ordinary shares | 135 | 45 % |
SR 1979 | Ordinary shares | 135 | 45 % |
| Ordinary shares | 15 | 5 % | |
BK | Ordinary shares | 15 | 5 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,224,698 | 2,190,732 | 1,941,091 | 1,808,762 | 1,548,274 |
Annual Total Result | 362,281 | 380,750 | 260,470 | 338,292 | 309,411 |
Total assets | 1,064,856 | 948,728 | 803,257 | 793,627 | 655,773 |
Total liabilities | 593,478 | 389,630 | 399,909 | 425,750 | 176,188 |
Total equity | 471,378 | 559,097 | 403,348 | 367,877 | 479,585 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,224,698 | 2,190,732 | 1,941,091 | 1,808,762 | 1,548,274 |
Total operating costs | 1,752,485 | 1,704,248 | 1,597,737 | 1,364,404 | 1,145,336 |
Operating result | 472,213 | 486,484 | 343,354 | 444,358 | 402,938 |
Financial income/costs | -449 | -4,585 | -862 | -175 | 0 |
Profit before tax | 471,764 | 481,900 | 342,492 | 444,183 | 402,938 |
Total tax & extraordinary income/cost | 109,483 | 101,150 | 82,022 | 105,891 | 93,527 |
Annual Total Result | 362,281 | 380,750 | 260,470 | 338,292 | 309,411 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 179,917 | 240,917 | 75,250 | 109,530 | 55,617 |
Total current assets | 884,939 | 707,811 | 728,007 | 684,097 | 600,155 |
Total assets | 1,064,856 | 948,728 | 803,257 | 793,627 | 655,773 |
Short term debt | 593,478 | 389,471 | 399,909 | 425,750 | 176,188 |
Long term debt | 0 | 160 | 0 | 0 | 0 |
Total liabilities | 593,478 | 389,630 | 399,909 | 425,750 | 176,188 |
Contributed capital | 24,680 | 24,680 | 24,680 | 24,680 | 24,680 |
Retained earnings | 446,698 | 534,417 | 378,668 | 343,197 | 454,905 |
Total equity | 471,378 | 559,097 | 403,348 | 367,877 | 479,585 |
Total equity and liabilities | 1,064,856 | 948,727 | 803,257 | 793,627 | 655,773 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises